Evaluation of Breast CT

University of California (UC) Davis

Status: Completed

Conditions: Breast Cancer

Treatments: Device: MRI; Device: computed tomography

Study type: Interventional

Funder types: Other; NIH

Identifiers

NCT00584233

1R01CA181081 (U.S. NIH Grant/Contract)

214750

Details and patient eligibility

About

The investigators have studied the potential of breast computed tomography (bCT) for breast imaging under an NIH-funded Biomedical Research Partnership (BRP) grant (R01 EB002138-10), and 4 breast CT scanners have been developed that have imaged over 600 women to date (under more than one IRB-approved protocol). The BRP grant cannot be renewed, and with this (resubmitted) R01 grant application, the investigators seek to finalize the investigators' research in breast CT - The specific aims have been significantly modified as a result of the first critique, and the investigators now focus on a narrower set of remaining issues.

This version of the protocol will add breast magnetic resonance imaging (MRI) to the experimental procedures.

Full description

Clinical evaluation: Four hundred women who will be having breast biopsy as part of their standard care (BIRADS 4 and 5) will be recruited to undergo additional imaging prior to biopsy, including (research) pre-and post-contrast enhanced breast CT imaging of both breasts, as well as (standard, FDA approved) contrast enhanced breast MRI. The potential of non-contrast enhanced breast CT will be compared using receiver operating characteristic (ROC) methodology against mammography alone, as well as with mammography + tomosynthesis. The breast CT images (including both pre-and post-contrast images) will be compared using ROC methodology against standard-of-care contrast-enhanced MRI (which includes both non-contrast and contrast images). The results of the clinical trials proposed in this investigation should provide strong evidence in regards to the potential of breast CT for breast cancer screening in the normal risk and high risk populations.

Enrollment: 75 patients

Sex: Female

Ages: 35+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Age at least 35 years old
• Diagnostic findings from prior mammography highly suggestive of breast malignancy (BI- RADS® category 4 or BI-RADS® category 5)
• Not pregnant or breast-feeding
• Ability to lie motionless for up to 5 minutes

Exclusion criteria

• Recent breast biopsy
• History of moderate or severe reaction to contrast agent injection
• History of Allergy to Iodine
• History of multiple food and/or drug allergy
• Currently taking Glucophage or Glucovance (Metformin)
• History of Chronic Asthma
• History of Diabetes Mellitus
• Renal (kidney) disease, or solitary kidney
• Recent lab tests showing elevated serum creatinine (≥ 1.5 mg/dL)
• Recent lab tests showing estimated glomerular filtration rate (eGFR) ≤ 60 ml/minute
• Positive urine pregnancy test or currently breast-feeding
• Inability to understand the risks and benefits of the study
• The standard MRI contraindications apply, including but not limited to: having a pacemaker or other implanted electronic device, metal foreign bodies within the eye, aneurysm clips, heart valve prosthesis, vascular stents, coils, intrauterine devices (IUDs), inferior vena cava (IVC) filters, gunshot wounds with retained bullet fragments.

Trial design

Primary purpose: Diagnostic

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

75 participants in 1 patient group

Breast CT and Breast MRI

Experimental group

Description:

Four hundred women who will be having breast biopsy as part of their standard care (BIRADS 4 and 5) will undergo pre- and post- contrast breast computed tomography and pre- and post- contrast magnetic resonance imaging.

Treatment:

Device: computed tomography

Device: MRI